——————————
融會傳統智慧創新科技
運用自然之力全面療癒身心靈
——————————
關於我們
安騰諾華是一家致力於提供天然、可持續和非抗生素的方法對抗微生物感染和相關疾病的生物科技初創公司。我們掌握先進的大學派生技術，並具備成就卓越的領導及顧問團隊，為實現以融會傳統智慧和創新技術運用大自然的力量去改善世界這抱負準備就緒。
遠象
不論是先祖傳承千年的知識，抑或最高端的科技——兩者安騰諾華都十分看重。我們堅信解決現今諸多生物醫學難題的答案，實際上一直寂寂無聲地隱藏在大自然的某個角落，而打開寶箱的鑰匙就在我們手裏：現代科學與技術。安騰諾華現時靠著先進的科學知識和技術，深入研究中醫藥以至其他自然資源，期望它們能幫助人類在理解和治療疾病上開展革命性的一頁。
我們展望一個不再受疾苦折騰的世界；
一個大家都能享受大自然祝福的世界；
一個我們能真正與萬物和諧共處的世界。
這個世界，我們稱之為
未來
使命
．
・
·
自第一種抗生素青黴素被發現以來，細菌對抗生素的抗藥性已經成為微生物學和醫學中廣泛討論的話題，而且仍然如此。抗生素的持續濫用為“超級細菌”提供了一個舒適的孵化床，這些細菌已經進化成為對許多抗生素具有抗藥性。此外，抗生素會不加選擇地殺死我們體內許多有益的細菌，對我們的健康造成了重大的、甚至是不可逆轉的損害。鑒於抗生素的有效性日益有限，且醫療保健系統在應對感染相關疾病方面的負擔沉重，迫切需要非抗生素替代方案。
PRO
SP
J
ECTS
PRO
ECTS
&
Staphylococcus Aureus
我們的第一個項目是尋找可以潛在地取代抗生素，對抗傳染性疾病，特別是對抗耐藥細菌的天然化合物。我們研究的化合物不是通過殺死細菌來達到治療的目的，而是通過抑制細菌的“致病性”，使它們在生存的同時不對我們造成任何危害。由於這些化合物具有抗致病性的特性，它們也被稱為“抗致病劑”。消除病原體的致病性是預防炎症的關鍵步驟，這不僅對於傷口治療至關重要，還可以降低由慢性炎症引起的疾病風險，如阿茲海默症、心臟疾病和糖尿病等。由於我們的皮膚和整體健康在自然老化過程中變得逐漸脆弱，保護自己免受細菌毒素和致病因子的傷害，已經不僅僅是醫生和患者的問題，而是每個人都需要關注的問題。我們正在研究的天然化合物將為我們提供強大的保護，通過有效地禁用細菌的“敵意”，而不會產生任何形式的抗藥性，從而有效地防止細菌對我們產生傷害。
毒力
病原體或微生物對宿主造成損害的能力
換言之，
敵意
More commonly called "S. aureus" or "Staph aureus," a pathogenic bacteria accounting for various kinds of infections, ranging from skin to bone infections. While it is estimated that about one-third of the population are healthy carriers of S. aureus, a considerable
percentage of the rest suffer from diseases associated with this bacteria, including general wound infections and eczema. Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of the bacteria resistant to most antibiotics we use nowadays. While MRSA can similarly cause diseases by normal S. aureus, it is also one of the leading causes of severe and even fatal infections in healthcare settings. Thus, non-antibiotic prevention and treatment of S. aureus infections is a critically pressing biomedical issue in our times.
我們最近已經成功地識別出了可能的候選物，這是一種獨特的植物化合物混合物，可以對金黃色葡萄球菌的致病性產生作用。基於一系列精心選擇的金黃色葡萄球菌工程菌株，我們能夠同時並即時地監測所有主要的致病性和毒素基因的表達。我們的實驗結果還表明，非常低劑量的天然化合物就能顯著抑制金黃色葡萄球菌的致病性。
Staphylococcus Aureus
More commonly called "S. aureus" or "Staph aureus," a pathogenic bacteria accounting for various kinds of infections, ranging from skin to bone infections. S. aureus can be found living transiently in the body of the majority of the world's population (70-90%), while one-third of the population are
persistent carriers of the bacteria. That means most of us are constantly exposed to the danger of S. aureus toxins and virulence factors, and are susceptible to skin inflammation and associated diseases, including general wound infections and eczema. Methicillin-resistant S. aureus (MRSA) is a strain of the bacteria resistant to most antibiotics we use nowadays. It is also one of the leading causes of severe and even fatal infections in healthcare settings. Thus, non-antibiotic prevention and treatment of S. aureus infections is a critically pressing biomedical issue in our times.
Fig. 1: Illustration of various inflammatory responses caused by S. aureus toxins in the skin, which result in inflammation, irritation and itch
(Chung et al. Pathogens. 2022)
PHYTO-
Related to or derived from plants.
At the current stage, our automated high-throughput screening system already allows us to provide rapid, sensitive detection service on the presence and abundance of virulence-promoting agents (VPAs) in product samples, and certify “VPA-free” products for clients.
We also see a promising future of S. aureus virulence-suppressing agents (VSAs) in the following applications:
- Treating eczema, diabetes-related ulcers, and various types of wounds
ECZEMA
ATOPIC
DERMATITIS
An incurable disease most prevalent among children and adolescents characterized by constant dryness, irritation, and inflammation of the skin. S. aureus has been reported to play a crucial role in aggravating the conditions as the bacteria produce toxins which cause inflammation across the skin. Eczema is also a risk factor for skin cancer as a result of chronic inflammation.
- Formulating S. aureus-neutralizing skincare products specifically for people with vulnerable skin, as well as for usual skincare routine by general consumers
- Preventing food poisoning caused by heat-resistant toxins produced by S. aureus
這只是開始—
Our vision goes beyond just tackling S. aureus and other bacteria. We are determined to discover more natural compounds that can help us combat a whole range of pathogenic microbes and diseases. With each new breakthrough, we move closer to a future where millions and billions of lives will be restored. This is not just a pipe dream, but a real possibility that we can make a reality. By investing in our research and working together, we can usher in a new era of healthcare that is not only effective but also sustainable. So let us keep our eyes fixed on the horizon, with hope and determination in our hearts, as we strive to make a better world for everyone.
在路途終結等待我們的，是一片燦爛的世界
處處機遇的世界
團隊
安騰諾華的團隊強大且經驗豐富，
由來自不同行業傑出人士擔任董事領導，
並具由國際知名的專家組成的顧問團隊。
